From: Comparison of radiotherapy combined with nimotuzumab vs. chemoradiotherapy for locally recurrent nasopharyngeal carcinoma
Endpoint
Factor
P
HR (95%CI)
OS
Age (years)
0.005
2.369 (1.293–4.342)
Recurrent T classification
0.003
4.875 (1.717–13.838)
PFS
GTV-T volume (cm3)
0.009
2.031 (1.190–3.467)
DMFS
EBV DNA following RT
0.047
3.294 (1.016–10.680)